Belvedere Trading’s Annovis Bio ANVS Stock Holding History

Belvedere Trading’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,778	Closed	-$27.5K	–	718
2024 Q2	$27.5K	Buy	+4,778	New	+$38.7K	﹤0.01%	551

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Belvedere Trading's ANVS Position: Q3 2024 in Review

Belvedere Trading sold out of Annovis Bio (ANVS) in Q3 2024, closing a stake of 4,778 shares — an estimated $27.5K sold.

Belvedere Trading first reported a position in ANVS in Q2 2024 and held it in 1 quarter. The position peaked at $27.5K in Q2 2024. 35 funds tracked by Wall St. Rank hold ANVS as of Q3 2024.

Belvedere Trading reported no remaining Annovis Bio position as of Q3 2024 after selling out during the quarter.
Belvedere Trading sold 4,778 Annovis Bio shares in Q3 2024, an estimated $27.5K.
Belvedere Trading first reported a position in Annovis Bio in Q2 2024 and held it in 1 quarter.
Belvedere Trading's Annovis Bio position peaked at $27.5K in Q2 2024.
35 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2024.

Based on Belvedere Trading's 13F filing for Q3 2024, filed 30 Oct 2024.